rofecoxib has been researched along with Pancreatitis, Chronic in 3 studies
Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Impact of rofecoxib on progressing of pancreatic fibrous changes in the rats in experimental chronic pancreatitis, caused by L-arginine, was studied up." | 7.79 | [New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats]. ( Berehova, TV; Falalieieva, TM; Petrushenko, VV; Sukhodolia, SA, 2013) |
| "Impact of rofecoxib on progressing of pancreatic fibrous changes in the rats in experimental chronic pancreatitis, caused by L-arginine, was studied up." | 3.79 | [New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats]. ( Berehova, TV; Falalieieva, TM; Petrushenko, VV; Sukhodolia, SA, 2013) |
| "Compared with the spontaneous development of inflammatory injury and fibrosis in WBN/Kob control rats, animals treated with rofecoxib exhibited a significant reduction and delay (p<0." | 3.73 | A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. ( Bimmler, D; Fortunato, F; Graf, R; Perren, A; Reding, T; Storni, F; Sun, LK, 2006) |
| "Chronic pancreatitis is a severe inflammation of the pancreas associated with destruction of the parenchyma, fibrosis, and persistent abdominal pain." | 1.37 | COX-2 is not required for the development of murine chronic pancreatitis. ( Bain, M; Graf, R; Heikenwalder, M; Reding, T; Silva, A; Sonda, S; Weber, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrushenko, VV | 1 |
| Sukhodolia, SA | 1 |
| Falalieieva, TM | 1 |
| Berehova, TV | 1 |
| Silva, A | 1 |
| Weber, A | 1 |
| Bain, M | 1 |
| Reding, T | 2 |
| Heikenwalder, M | 1 |
| Sonda, S | 1 |
| Graf, R | 2 |
| Bimmler, D | 1 |
| Perren, A | 1 |
| Sun, LK | 1 |
| Fortunato, F | 1 |
| Storni, F | 1 |
3 other studies available for rofecoxib and Pancreatitis, Chronic
| Article | Year |
|---|---|
[New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats].
Topics: Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Cyclooxygenase 2 Inhibitors; F | 2013 |
COX-2 is not required for the development of murine chronic pancreatitis.
Topics: Actins; Age Factors; Animals; Ceruletide; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; D | 2011 |
A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.
Topics: Animals; Cell Movement; Chemotactic Factors; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 In | 2006 |